SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-370974
Filing Date
2015-11-09
Accepted
2015-11-09 07:01:02
Documents
16
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d60961d10q.htm 10-Q 546828
2 EX-10.1 d60961dex101.htm EX-10.1 29686
3 EX-10.2 d60961dex102.htm EX-10.2 25681
4 EX-10.3 d60961dex103.htm EX-10.3 9064
5 EX-10.4 d60961dex104.htm EX-10.4 6777
6 EX-10.5 d60961dex105.htm EX-10.5 34214
7 EX-31.1 d60961dex311.htm EX-31.1 5995
8 EX-31.2 d60961dex312.htm EX-31.2 6007
9 EX-32.1 d60961dex321.htm EX-32.1 3394
10 EX-32.2 d60961dex322.htm EX-32.2 3435
  Complete submission text file 0001193125-15-370974.txt   2688782

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT kpti-20150930.xml EX-101.INS 399789
12 XBRL TAXONOMY EXTENSION SCHEMA kpti-20150930.xsd EX-101.SCH 29372
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20150930_cal.xml EX-101.CAL 47473
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20150930_def.xml EX-101.DEF 89012
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20150930_lab.xml EX-101.LAB 264185
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20150930_pre.xml EX-101.PRE 176911
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 151213933
SIC: 2834 Pharmaceutical Preparations